ep. 141 - neoantigen vaccines, drug pricing, u.s.-china & u.k. turmoil
Published 6 months ago • 7 plays • Length 25:34
Download video MP4
Download video MP3
Similar videos
-
9:10
germany's evonik's expanded plant in singapore is world's largest methionine production facility
-
2:26
nhia reduces prices of 5,400 drugs|20230304 pts english news公視英語新聞
-
19:27
ep. 154 - madrigal in nash, moderna & neoantigens, the distillery
-
31:53
ep. 221 - china biocontroversy, plus: diversity matters
-
0:50
china's sinopharm says vaccine 79% effective vs coronavirus
-
8:57
how the prescription drug supply chain is killing local pharmacies
-
46:26
ft pharma 2021 - pricing and market access trends session
-
25:41
how much money does the world owe china? | counting the cost
-
1:15:01
understanding drug pricing in the us
-
21:14
ep. 114 - hutchmed setback, fda in focus, hillevax's ipo
-
2:34
china's first drugs for covid-19 treatment complete development in under 20 months
-
2:14
china approves first homegrown covid-19 vaccine by sinopharm for general use | the world
-
26:36
ep. 139 - wins in neurodegeneration, u.s.-china & life science cares
-
40:23
ep. 62 - rick bright: navigating the avian flu threat
-
0:55
china's sinovac-coronavac covid-19 vaccine approved by who - #shorts
-
28:54
ep. 42 - panacea's james huang
-
20:24
ep. 28 - fda's future & china summit preview
-
26:50
ep. 151 - alzheimer's takeaways, u.k. biotech, charles forum
-
23:29
ep. 85 - what's next for crispr & gene therapy, plus china summit preview
-
29:45
ep. 214 - bms’s patent cliff, congress targets china biotech
-
3:38
palace: not all sinopharm vaccines will be returned to china | anc
-
6:47
glaxosmithkline's ceo on the china controversy, transparency, and big pharma's reputation | forbes
Clip.africa.com - Privacy-policy